Multipl Sklerozda Etiyoloji ve Genetik

Tan H, Özden Ö. Vitamin D ve Multipl Skleroz. Turkiye Klinikleri J Pediatr Sci. 2012;8(2):110-3.

Samur BM, Pashayev A, Canpolat M. Çocukluk çağında multipl skleroz. Canpolat M, editör. Nöroimmünoloji. 1. Baskı. Ankara: Türkiye Klinikleri; 2023. p.43-73.

Martyn CN, Gale CR. The epidemiology of multiple sclerosis. Acta Neurol Scand 1998; 169:3-7.

Milonas I, Tsunis STL, Logothetis I. Epidemiology of multiple sclerosis in northern Greece. Acta Neurol Scand 1990; 81: 43-47.

Ebers GC, Sadovnick AD. Epidemiology. In: Paty DW, Ebers GC (eds), Multiple Sclerosis. FA Davis Company, Philadelphia 1998, pp 5-28.

Mirza M. Multipl Sklerozun Epidemiyoloji ve Etyolojisi. Erciyes Tıp Dergisi (Erciyes Medical Journal) 2002; 24 40 (1) 40-47.

Katz Sand, I. (2018). The role of diet in multiple sclerosis: mechanistic connections and current evidence. Current nutrition reports, 7, 150-160.

Riccio, P. ve Rossano, R. (2015). Nutrition facts in multiple sclerosis. ASN neuro, 7(1), 1759091414568185.

Yıldırım Z, Yıldırım İ. G. Glütensiz Diyet Multiple Skleroz Hastalığında Etkili Olabilir Mi? Mini Bir Derleme. Başkent Üniversitesi Sağlık Bilimleri Fakültesi Dergisi. 2024, 9(1), 74-85.

Beckett, J. M., Bird, M.-L., Pittaway, J. K. ve Ahuja, K. D. (2019). Diet and multiple sclerosis: scoping review of web-based recommendations. Interactive journal of medical research, 8(1), e10050.

Shor, D. B. A., Barzilai, O., Ram, M., Izhaky, D., Porat‐Katz, B. S, Chapman, J, Shoenfeld, Y. (2009). Gluten sensitivity in multiple sclerosis: experimental myth or clinical truth? Annals of the New York Academy of Sciences, 1173(1), 343-349.

Ullah, H., Tovchiga, O., Daglia, M. ve Khan, H. (2021). Modulating gut microbiota: an emerging approach in the prevention and treatment of multiple sclerosis. Current Neuropharmacology, 19(11), 1966.

Ahmadabadi, A. B., Shahbazkhani, B., Tafakhori, A., Khosravi, A. ve Mashhadi, M. M. (2018). A genetic study of celiac disease in patients with multiple sclerosis in comparison with celiac patients and healthy controls. Govaresh, 22(4), 256-260.

Mische, L. J. ve Mowry, E. M. (2018). The evidence for dietary interventions and nutritional supplements as treatment options in multiple sclerosis: a review. Current treatment options in neurology, 20, 1-11.

Özdemir M, Ayaz A. Multipl Skleroz’da K Vitamininin Rolü Var Mıdır? Kocatepe Tıp Dergisi, 2020;21:362-369.

Ferland G. The discovery of vitamin K and its clinical applications. Ann Nutr Metab. 2012;61(3):213-8.

Binder MD, Xiao J, Kemper D, Ma GZ, Murray SS, Kil¬patrick TJ. Gas6 increases myelination by oligodendrocy¬tes and its deficiency delays recovery following cuprizo¬ne-induced demyelination. PloS one. 2011;6(3):e17727.

Sainaghi PP, Collimedaglia L, Alciato F, Molinari R, Sola D, Ranza E, et al. Growth arrest specific gene 6 pro¬tein concentration in cerebrospinal fluid correlates with relapse severity in multiple sclerosis. Mediators Inflamm. 2013;406483.

Crivello NA, Casseus SL, Peterson JW, Smith DE, Bo¬oth SL. Age- and brain region-specific effects of die¬tary vitamin K on myelin sulfatides. J. Nutr. Biochem. 2010;21(11):1083-8.

Lasemi R, Kundi M, Moghadam NB, Moshammer H, Hainfellner JA. Vitamin K2 in multiple sclerosis patients. Wien Klin Wochenschr. 2018;130(9-10):307-13.

Irish AK, Erickson CM, Wahls TL, Snetselaar LG, Darling WG. Randomized control trial evaluation of a modified Paleolithic dietary intervention in the treatment of relap¬sing-remitting multiple sclerosis: a pilot study. Degener Neurol Neuromuscul Dis. 2017;7:1-18.

Moriya M, Nakatsuji Y, Okuno T, Hamasaki T, Sawada M, Sakoda S. Vitamin K2 ameliorates experimental auto¬immune encephalomyelitis in Lewis rats. J Neuroimmu¬nol. 2005;170(1-2):11-20.

Popescu DC, Huang H, Singhal NK, Shriver L, McDo¬nough J, Clements RJ, et al. Vitamin K enhances the pro¬duction of brain sulfatides during remyelination. PloS one. 2018;13(8):e0203057.

Küçükyılmaz K. Multiple Sklerozda D vitamininin Rolü. Adnan Menderes Üniversitesi Sağlık Bilimleri Fakültesi Dergisi, 2023;7(3); 742-755.

Feige, J., Moser, T., Bieler, L., Schwenker, K., Hauer, L., & Sellner, J. (2020). Vitamin D supplementation in multiple sclerosis: a critical analysis of potentials and threats” Nutrients, 12(3), 783.

Özkan, B., & Döneray, H. D vitamininin iskelet sistemi dışı etkileri. Çocuk Sağlığı ve Hastalıkları Dergisi, 2011;54(2), 99-119.

Gselman, S.; Fabjan, T.H.; Bizjak, A.; Potoˇcnik, U.; Gorenjak, M. Cholecalciferol Supplementation Induced Up-Regulation of SARAF Gene and Down-Regulated miR-155-5p Expression in Slovenian Patients with Multiple Sclerosis. Genes 2023, 14, 1237.

Sabel C. E, Pearson, J. F, Mason, D. F, Willoughby, E, Abernethy, D. A, &Taylor, B. V. (2021). The latitude gradient for multiple sclerosis prevalence is established in the early life course. Brain, 144(7), 2038-2046.

Nielsen, N. M, Munger, K. L, Koch-Henriksen, N, Hougaard, D. M, Magyari, M, Jørgensen K. T., et al. (2017). Neonatal vitamin D status and risk of multiple sclerosis: A population-based case-control study. Neurology, 88(1), 44-51.

Toprak K. M, Alkan B. D Vitamini ve Multipl Skleroz Patogenezindeki Yeri. Türkiye Klinikleri Dergisi, MS ve Sağlıklı Yaşam- Ana Tema: ''MS Oluşumunda ve Seyrinde Değiştirilebilir Risk Faktörleri'' 2020;p.46-61

De Mol C. L, Lamballais S, Muetzel R, et al. Environmental multiple sclerosis (MS) risk factors, genetic MS risk, and brain development in a general paediatric population. J Neurol Neurosurg Psychiatry 2024 Dec 10:jnnp-2024-335053. doi: 10.1136/jnnp-2024-335053

Manna I, De Benedittis S, Porro D. A Comprehensive Examination of the Role of Epigenetic Factors in Multiple Sclerosis. Int. J. Mol. Sci. 2024, 25, 8921. https://doi.org/10.3390/ijms25168921

33)Beckmann Y, Uzunköprü C. Multipl Skleroz. Subaşıoğlu A. Multipl Skleroz ve Genetik. EMA Tıp Kitabevi, 2021:41-53

Ramagopalan S.V, Sadovnick A.D. Epidemiology of multiple sclerosis. Neurol Clin 2011 May;29(2):207-17. doi: 10.1016/j.ncl.2010.12.010.

Parıltay E, Solmaz A.E, Arıcan D, Çoğulu Ö. Multipl Skleroz ve Epigenetik MS ve Sağlıklı Yaşam- Ana Tema:’’ MS Oluşumunda ve Seyrinde Değiştirilebilir Risk Faktörleri’’.Türkiye Klinikleri. 2020;5-10.

Sarıdaş F. Multiple Skleroz Gelişimi ile İlişkili miRNA’ların Araştırılması. Bursa Uludag University (Turkey) ProQuest Dissertations & Theses, 2018. 28743208.

Agnello, L., Scazzone, C., Sasso B. L., Ragonese P., Milano S., Salemi G., et al. (2018). CYP27A1, CYP24A1, and RXR-α Polymorphisms, Vitamin D, and Multiple Sclerosis: a Pilot Study. J Mol Neurosci, 66(1), 77-84.

Gil-Varea E, Urcelay E, Vilariño-Güell C. Exome sequencing study in patients with multiple sclerosis reveals variants associated with disease course. Journal of Neuroinflammation (2018) 15:265 https://doi.org/10.1186/s12974-018-1307-1

International Multiple Sclerosis Genetics Consortium. Collaborators expand. Multipl sclerosis genomic map implicatesperipheral immüne cells and microglia in susceptibility. Science, 2019 Sep 27;365(6460):eaav7188. doi: 10.1126/science.aav7188.

Patsopoulos NA. International Multiple Sclerosis Genetics Consortium. 2016. 200 loci complete the genetic puzzle of multiple sclerosis. American Society of Human Genetics 2016 Annual Meeting, Abstract 4/6. Vancouver, Canada, October 18–22.

Fortner DM, Troy RG, Brow DA. 1994. A stem/loop in U6 RNA defines a conformational switch required for pre-mRNA splicing. Genes Dev 8: 221–233.

Patsopoulos NA. Genetics of Multiple Sclerosis: An Overview and New Directions.

Cold Spring Harb Perspect Med. 2018 Jul 2;8(7):a028951. doi: 10.1101/cshperspect.a028951.

Ramagopalan SV, Dyment DA, Cader MZ, Morrison KM, Disanto G, Morahan JM, Berlanga-Taylor AJ, Handel A, De Luca GC, Sadovnick AD, et al. 2011. Rare variants in the CYP27B1 gene are associated with multiple sclerosis. Ann Neurol 70: 881–886

Wang Z, Sadovnick AD, Traboulsee AL, Ross JP, Bernales CQ, Encarnacion M, Yee IM, de Lemos M, Greenwood T, Lee JD, et al. 2016. Nuclear receptor NR1H3 in familial multiple sclerosis. Neuron 90: 948–954.

International Multiple Sclerosis Genetics Consortium. 2016. NR1H3 p.Arg415Gln is not associated to multiple sclerosis risk. Neuron 92: 333–335.

Horton K. M, Shim E.J, Wallace A. Rare And Low-Frequency Codıng Genetıc Varıants Contrıbute To Pedıatrıc-Onset Multıple Sclerosıs. Mult Scler. 2023 Feb 8;29(4-5):505–511. doi: 10.1177/13524585221150736

Jakimovski D, Bittner S, Zivadinov R, et al. Multiple sclerosis. Lancet 2024 Jan 13;403(10422):183-202. doi: 10.1016/S0140-6736(23)01473-3.

Emami Nejad A, Mostafavi Zadeh SM, Nickho H, Sadoogh Abbasian A, Forouzan A, Ahmadlou M, Nedaeinia R, Shaverdi S and Manian M (2023) The role of microRNAs involved in the disorder of blood–brain barrier in the pathogenesis of multiple sclerosis. Front. Immunol. 14:1281567. doi: 10.3389/fimmu.2023.1281567

Regev K, Paul A, Healy B, von Glenn F, Diaz-Cruz C, Gholipour T, et al. Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosis. Neurology(R) neuroimmunology neuroinflammation 2016;3(5):e267.

Du C, Liu C, Kang J, Zhao G, Ye Z, Huang S, et al. MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat Immunol (2009) 10(12):1252–9. doi: 10.1038/ni.1798

Junker A, Krumbholz M, Eisele S, Mohan H, Augstein F, Bittner R, et al. MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain J Neurol (2009) 132(Pt 12):3342–52. doi:10.1093/brain/awp300

Otaegui D, Baranzini SE, Armañanzas R, Calvo B, Muñoz-Culla M, Khankhanian P, et al. Differential micro RNA expression in PBMC from multiple sclerosis patients. PLoS One (2009) 4(7):e6309. doi: 10.1371/journal.pone.0006309

Zhang Y, Zhang D, Wang F, Xu D, Guo Y, Cui W. Serum miRNAs panel (miR-16-2*, miR-195, miR-2861, miR-497) as novel non-invasive biomarkers for detection of cervical cancer. Sci Rep (2015) 5:17942. doi: 10.1038/srep17942